| Briona Thielen, | |
|
806 N Washington St, Bismarck, ND 58501-3623 | |
| (701) 323-4029 | |
| Not Available |
| Full Name | Briona Thielen |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 806 N Washington St, Bismarck, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992487771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2414 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Briona Thielen, 806 N Washington St, Bismarck, ND 58501-3623 Ph: (701) 323-4029 | Briona Thielen, 806 N Washington St, Bismarck, ND 58501-3623 Ph: (701) 323-4029 |
News Archive
Dyax Corp. today announced the pricing of an underwritten public offering of 17,000,000 shares of its common stock at a price to the public of $3.25 per share. The gross proceeds from the sale of shares, after underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $51.8 million. The offering is expected to close on or about March 30, 2010, subject to customary closing conditions.
Including smoking cessation with existing lung cancer screening efforts would reduce lung cancer mortality by 14 percent and increase life-years gained by 81 percent compared with screening alone, according to a study from Rafael Meza from the University of Michigan and colleagues and published in the Journal of Thoracic Oncology, a publication of the International Association for the Study of Lung Cancer.
The National Nanotechnology Initiative (NNI) today published the report from the workshop, "Stakeholder Perspectives on Perception, Assessment, and Management of the Potential Risks of Nanotechnology" (R3 Workshop), which was held September 10-11, 2013, in Washington, D.C.
The Food and Drug Administration (FDA) ensures that high-risk medical devices, such as implantable cardioverter-defibrillators and pacemakers, are safe and effective through its premarket approval (PMA) pathway, during which manufacturers must collect preclinical and clinical data before the device is approved.
› Verified 3 days ago
Mrs. Kelli Katharina Ellenbaum, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2625 N 19th St, Bismarck, ND 58503 Phone: 701-222-3175 Fax: 701-222-3186 | |
Sierra Larae Burgess, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 210 S 12th St, Bismarck, ND 58504 Phone: 701-222-3175 Fax: 701-222-3186 | |
Rebecca Mcgillivray, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 720 N 14th St, Bismarck, ND 58501 Phone: 701-323-4400 | |
Mrs. Karen Kaylene Davis, M. A. Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1600 E Interstate Ave Ste 3, Bismarck, ND 58503 Phone: 701-751-1125 Fax: 701-751-0729 | |
Linaya Ming, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2625 N 19th St, Bismarck, ND 58503 Phone: 701-222-3175 Fax: 701-222-3186 | |
Donna Johnson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 806 N Washington St, Bismarck, ND 58501 Phone: 701-323-4028 Fax: 701-323-4027 | |
Kourtney Carr, M.S. SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 806 N Washington St, Bismarck, ND 58501 Phone: 701-323-4028 Fax: 701-323-4027 |